Table 3 Summary of adverse events, N (%) of patients
Adverse events | Group A | Group B |
|---|---|---|
Dysphagia | 10 (31.3 %) | 6 (16.7 %) |
Neck muscle weakness | 5 (15.6) | 6 (16.7 %) |
Discomfort at injection site | 3 (9.4 %) | 7 (19.4) |
Dry mouth | 2 (6.3 %) | 3 (8.3 %) |
Patients with ≥1 adverse events | 17 (53.1 %) | 19 (52.8 %) |